100 CAMBRIDGEPARK DRIVE, CAMBRIDGE, MA
Director Resignation and Appointment - Andrew Levin and David Zaccardelli
News, Material Contracts
Receives NMPA Approval for the Treatment of Sjögren’s Disease in China
Annual Report to Security Holders
Material Contracts, Unregistered Sales of Equity Securities, Reg. FD
Investor Presentation
Separation Agreement with Dr. Qing Zuraw; Chief Development Officer Departs
Announces $150 Million Private Placement
Q1
FY 2025
Q3
Q2
FY 2024
Q2 amended
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership